CMLF
Get informed when a big investor buys or sells
+ Follow| Market cap | $344.64 Million |
|---|---|
| Enterprise Value | $354.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.73 |
| Beta | 0 |
| Outstanding Shares | 29,710,139 |
| P/E Ratio | -3.14 |
|---|---|
| PEG | 1.19 |
| Price to Sales | 0.77 |
| Price to Book Ratio | 1.45 |
| Enterprise Value to Revenue | 0.78 |
| Enterprise Value to EBIT | -4.34 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.29 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
CM Life Sciences was founded to take advantage of a dynamic life science sector buoyed by innovation yet fragmented, where many companies are under-resourced and under-scaled. Significant and under-appreciated opportunities for consolida...